ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC

ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC ntaylor Thu, 05/14/2020 - 08:11

ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC
ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC ntaylor Thu, 05/14/2020 - 08:11